Bionic Pancreas Outperforms Standard Care for Type 1 Diabetes in Trial

An investigational bionic pancreas that makes insulin dose decisions based on patient body weight and meal announcements without carbohydrate counts did a better job of keeping blood glucose within target ranges than standard care in a recent trial.